PALL EBDS BDS02

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a user facility report with the FDA on 2016-06-02 for PALL EBDS BDS02 manufactured by Haemonetics Corp.

Event Text Entries

[46432225] The platelet unit collected at the reporting facility was sampled and stored appropriately according to the facility protocols. The unit passed bacterial testing using the ebds bacterial detection system on (b)(6) 2016 on the mother platelet storage bag. The platelet unit was tested at the hospital microbiology lab after the transfusion reaction and was positive for staphylococcus aureus. The device is not being returned. There was no platelet sample returned to haemonetics for testing. Staphylococcus aureus should have been detected by the ebds if the test was performed correctly, but in mitigation, if the sampling was conducted at a time when the bacteria in the mother platelet storage bag had not grown sufficiently to be captured in the ebds pouch during the sampling process, or the incubation period/conditions were not correct, then the level for detection by the ebds was not reached. There are other possible points in the splitting into daughter platelet bags and transfusion preparation process that could have been the cause of the contamination. The root cause is inconclusive as no samples were returned for evaluation. Not returned.
Patient Sequence No: 1, Text Type: N, H10


[46432226] Haemonetics received a complaint that the pall enhanced bacterial detection system (pall ebds) returned a false negative result which resulted in a transfusion reaction. It was reported to haemonetics that a hospital end-user transfused one unit of platelets to a patient receiving chemotherapy for relapsed ph+ acute lymphoblastic leukemia. The collected platelet unit had been tested at the collection site for bacterial contamination using the ebds device. The test did not detect bacterial growth. No testing was done at the hospital prior to transfusion. The transfusion resulted in a reaction with fever, chest tightness, dyspnea, back pain, flank pain and nausea. The transfusion was stopped and a transfusion reaction workup initiated; ua and blood cultures sent as well as bb samples. The patient has no prior history of reactions. The patient required additional medical intervention with antibiotic treatment receiving daptomycin, oxacillin, and clindamycin in addition to vancomycin which was prescribed pre-transfusion. The patient developed septic shock which subsequently resolved and all blood cultures are negative.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219343-2016-00037
MDR Report Key5695358
Report SourceUSER FACILITY
Date Received2016-06-02
Date of Report2016-05-03
Date of Event2016-05-02
Date Mfgr Received2016-05-03
Device Manufacturer Date2014-07-01
Date Added to Maude2016-06-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS JULIE SMITH, RN
Manufacturer Street400 WOOD RD
Manufacturer CityBRAINTREE MA 02184
Manufacturer CountryUS
Manufacturer Postal02184
Manufacturer Phone7819170643
Manufacturer G1HAEMONETICS CORP
Manufacturer Street400 WOOD RD
Manufacturer CityBRAINTREE MA 02184
Manufacturer CountryUS
Manufacturer Postal Code02184
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePALL EBDS
Generic NameSYSTEM,DETECTION,BACTERIAL, FOR PLATELET TRANSFUSION PRODUCTS
Product CodeMZC
Date Received2016-06-02
Model NumberBDS02
Catalog NumberBDS02
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerHAEMONETICS CORP
Manufacturer Address400 WOOD RD BRAINTREE MA 02184 US 02184


Patients

Patient NumberTreatmentOutcomeDate
14001. Hospitalization 2016-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.